Novo Holdings led Kate Farms' Series C financing in 2022 and supported its continued growth as the company's largest institutional investor
Transaction highlights the Planetary...
Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...
Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...
Landmark investments, portfolio progress, and expanded presence positionNovo Holdings for long-term growth and impact in Asia
SINGAPORE, June 18, 2025 /PRNewswire/ -- Novo Holdings today released...